Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengfu Xu

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Msystems|October 20, 2025
Microbial changes resulting from VSG attenuate MASLD by modulating bile acid metabolism and the intestinal FXR-FGF19 axisYi Xia, Jinpu Yang, Shixian Lu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2016
Cutting Edge: Expression of IRF8 in Gastric Epithelial Cells Confers Protective Innate Immunity against Helicobacter pylori InfectionMing Yan, Hongsheng Wang, Jiafang Sun, et al.
Hepatology International|July 2, 2020
Silencing of functional p53 attenuates NAFLD by promoting HMGB1-related autophagy inductionXuequn Zhang, Yiming Lin, Sisi Lin, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 20, 2021
GCSF deficiency attenuates nonalcoholic fatty liver disease through regulating GCSFR-SOCS3-JAK-STAT3 pathway and immune cells infiltrationYuwei Zhang, Xuefeng Zhou, Peihao Liu, et al.
Hepatology (Baltimore, Md.)|February 18, 2010
Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a hydratase down-regulation exacerbates hepatic steatosisXuequn Zhang, Juntao Yang, Yuanbiao Guo, et al.
Plos One|April 28, 2012
Decreased levels of active SMAD2 correlate with poor prognosis in gastric cancerYijun Wu, Qi Li, Xinhui Zhou, et al.
Cell Metabolism|August 14, 2024
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASHLiang Tao, Xinquan Yang, Chaodong Ge, et al.
Biochemistry|June 24, 2014
Functional annotation and structural characterization of a novel lactonase hydrolyzing D-xylono-1,4-lactone-5-phosphate and L-arabino-1,4-lactone-5-phosphateMagdalena Korczynska, Dao Feng Xiang, Zhening Zhang, et al.
Endoscopy|October 24, 2024
A novel endoscopic artificial intelligence system to assist in the diagnosis of autoimmune gastritis: a multicenter studyShurong Chen, Louzhe Xu, Lingling Yan, et al.
The American Journal of Pathology|May 13, 2016
Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine ExpressionZhe Shen, Yan Liu, Bedair Dewidar, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Msystems|October 20, 2025
Microbial changes resulting from VSG attenuate MASLD by modulating bile acid metabolism and the intestinal FXR-FGF19 axisYi Xia, Jinpu Yang, Shixian Lu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2016
Cutting Edge: Expression of IRF8 in Gastric Epithelial Cells Confers Protective Innate Immunity against Helicobacter pylori InfectionMing Yan, Hongsheng Wang, Jiafang Sun, et al.
Hepatology International|July 2, 2020
Silencing of functional p53 attenuates NAFLD by promoting HMGB1-related autophagy inductionXuequn Zhang, Yiming Lin, Sisi Lin, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 20, 2021
GCSF deficiency attenuates nonalcoholic fatty liver disease through regulating GCSFR-SOCS3-JAK-STAT3 pathway and immune cells infiltrationYuwei Zhang, Xuefeng Zhou, Peihao Liu, et al.
Hepatology (Baltimore, Md.)|February 18, 2010
Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a hydratase down-regulation exacerbates hepatic steatosisXuequn Zhang, Juntao Yang, Yuanbiao Guo, et al.
Plos One|April 28, 2012
Decreased levels of active SMAD2 correlate with poor prognosis in gastric cancerYijun Wu, Qi Li, Xinhui Zhou, et al.
Cell Metabolism|August 14, 2024
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASHLiang Tao, Xinquan Yang, Chaodong Ge, et al.
Biochemistry|June 24, 2014
Functional annotation and structural characterization of a novel lactonase hydrolyzing D-xylono-1,4-lactone-5-phosphate and L-arabino-1,4-lactone-5-phosphateMagdalena Korczynska, Dao Feng Xiang, Zhening Zhang, et al.
Endoscopy|October 24, 2024
A novel endoscopic artificial intelligence system to assist in the diagnosis of autoimmune gastritis: a multicenter studyShurong Chen, Louzhe Xu, Lingling Yan, et al.
The American Journal of Pathology|May 13, 2016
Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine ExpressionZhe Shen, Yan Liu, Bedair Dewidar, et al.
Pageof 15